SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+17.19%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$189M
AUM Growth
+$189M
(+15%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
6.75%
Top 10 Holdings %
Top 10 Hldgs %
41.3%
Holding
79
New
19
Increased
18
Reduced
20
Closed
16
Top Buys
| 1 |
Mersana Therapeutics
MRSN
|
$7.32M |
| 2 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$7.32M |
| 3 |
Natera
NTRA
|
$7.3M |
| 4 |
Lantheus
LNTH
|
$6.46M |
| 5 |
TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
|
$5.73M |
Top Sells
| 1 |
Zymeworks
ZYME
|
$15.4M |
| 2 |
Prothena Corp
PRTA
|
$7.06M |
| 3 |
AstraZeneca
AZN
|
$6.96M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$3.63M |
| 5 |
Spyre Therapeutics
SYRE
|
$3.42M |
Sector Composition
| 1 | Healthcare | 94.21% |
| 2 | Real Estate | 0.86% |
